Bristol-Myers Squibb Company
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionMarathon Capital Management
Latest Disclosed Ownership8,324 shares
Latest Disclosed Value $ 504,835
Marathon Capital Management reports 2.80% decrease in ownership of BMY / Bristol-Myers Squibb Company

On May 14, 2026 - Marathon Capital Management filed a 13F-HR form disclosing ownership of 8,324 shares of Bristol-Myers Squibb Company (US:BMY) valued at $504,851 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 8,564 shares of Bristol-Myers Squibb Company. This represents a change in shares of -2.80% during the quarter. The current value of the position is $476,715 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,324 -240 -2.80 505 9.33 0.1134
2026-01-29 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,564 0 0.00 462 19.43 0.0994
2025-11-14 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 8,564 755 9.67 386 6.93 0.0884
2025-08-14 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,809 -955 -10.90 361 -32.40 0.0921
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,764 -44 -0.50 535 7.23 0.1424
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 8,808 263 3.08 498 12.67 0.1244
2024-11-14 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 8,545 -175 -2.01 442 22.10 0.1072
2024-08-14 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 8,720 -106,160 -92.41 362 -94.19 0.0923
2024-05-15 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 114,880 746 0.65 6,230 6.37 1.4866
2024-02-14 2023-12-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 114,134 -6,593 -5.46 5,856 -16.41 1.4720
2024-02-08 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 114,134 -6,593 5,856 1.4720
2023-11-14 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 120,727 1,185 0.99 7,007 -8.35 1.7633
2023-08-15 2023-06-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 119,542 -943 -0.78 7,645 -8.46 1.8871
2023-08-14 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 119,542 -943 7,645 1.8518
2023-05-12 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 120,485 19,228 18.99 8,351 14.62 2.0549
2023-02-14 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 101,257 -29 -0.03 7,285 1.18 2.0081
2022-11-14 2022-09-30 13F Bristol-Myers Squibb COM 110122108 101,286 27,033 36.41 7,200 25.94 2.0569
2022-08-12 2022-06-30 13F Bristol-Myers Squibb COM 110122108 74,253 -17,110 -18.73 5,717 -14.31 1.8468
2022-05-13 2022-03-31 13F Bristol-Myers Squibb COM 110122108 91,363 -105 -0.11 6,672 16.99 1.9152
2022-02-09 2021-12-31 13F Bristol-Myers Squibb COM 110122108 91,468 -502 -0.55 5,703 4.80 1.3364
2021-11-15 2021-09-30 13F Bristol-Myers Squibb COM 110122108 91,970 15,751 20.67 5,442 6.87 1.2354
2021-08-16 2021-06-30 13F Bristol-Myers Squibb COM 110122108 76,219 -811 -1.05 5,092 4.73 1.1788
2021-05-14 2021-03-31 13F Bristol-Myers Squibb COM 110122108 77,030 10,238 15.33 4,862 17.35 1.2817
2021-02-08 2020-12-31 13F Bristol-Myers Squibb COM 110122108 66,792 3,754 5.96 4,143 9.03 1.2211
2020-11-16 2020-09-30 13F Bristol-Myers Squibb COM 110122108 63,038 -2,154 -3.30 3,800 -0.86 1.3833
2020-08-14 2020-06-30 13F Bristol-Myers Squibb COM 110122108 65,192 -46 -0.07 3,833 5.42 1.4723
2020-05-15 2020-03-31 13F Bristol-Myers Squibb COM 110122108 65,238 13,204 25.38 3,636 8.86 1.6694
2020-02-14 2019-12-31 13F Bristol-Myers Squibb COM 110122108 52,034 31,057 148.05 3,340 213.91 1.1358
2019-11-13 2019-09-30 13F Bristol-Myers Squibb COM 110122108 20,977 840 4.17 1,064 16.54 0.4291
2019-07-25 2019-06-30 13F Bristol-Myers Squibb COM 110122108 20,137 6,230 44.80 913 37.71 0.3723
2019-05-15 2019-03-31 13F Bristol-Myers Squibb COM 110122108 13,907 9,183 194.39 663 170.61 0.2961
2019-02-07 2018-12-31 13F Bristol-Myers Squibb COM 110122108 4,724 -1,645 -25.83 245 -39.80 0.1216
2016-05-13 2016-03-31 13F Bristol-Myers Squibb EQ 110122108 6,369 0 0.00 407 -7.08 0.2106
2016-02-12 2015-12-31 13F Bristol-Myers Squibb EQ 110122108 6,369 300 4.94 438 22.01 0.2319
2015-11-12 2015-09-30 13F Bristol-Myers Squibb COM 110122108 6,069 -75 -1.22 359 -12.22 0.1823
2015-08-11 2015-06-30 13F Bristol-Myers Squibb COM 110122108 6,144 71 1.17 409 4.34 0.1886
2015-05-06 2015-03-31 13F Bristol-Myers Squibb COM 110122108 6,073 1,050 20.90 392 31.99 0.1738
2015-02-09 2014-12-31 13F Bristol-Myers Squibb COM 110122108 5,023 -1,500 -23.00 297 -11.08 0.2737
2014-10-30 2014-09-30 13F Bristol-Myers Squibb COM 110122108 6,523 -1,200 -15.54 334 -10.93 0.3009
2014-08-08 2014-06-30 13F Bristol-Myers Squibb COM 110122108 7,723 0 0.00 375 -6.48 0.3017
2014-04-30 2014-03-31 13F Bristol-Myers Squibb COM 110122108 7,723 0 0.00 401 -2.20 0.3013
2014-01-28 2013-12-31 13F Bristol-Myers Squibb COM 110122108 7,723 0 0.00 410 14.85 0.2958
2013-11-04 2013-09-30 13F Bristol-Myers Squibb COM 110122108 7,723 0 0.00 357 3.48 0.3067
2013-07-25 2013-06-30 13F Bristol-Myers Squibb COM 110122108 7,723 7,723 345 0.2945
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.